Epstein-Barr Virus Nuclear Antigens
"Epstein-Barr Virus Nuclear Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Nuclear antigens encoded by VIRAL GENES found in HUMAN HERPESVIRUS 4. At least six nuclear antigens have been identified.
| Descriptor ID |
D019309
|
| MeSH Number(s) |
D23.050.290.249 D23.050.327.300
|
| Concept/Terms |
Epstein-Barr Virus Nuclear Antigens- Epstein-Barr Virus Nuclear Antigens
- Epstein Barr Virus Nuclear Antigens
- Nuclear Antigens, Herpesvirus 4, Human
- EBV Nuclear Antigens
- Nuclear Antigens, EBV
- Herpesvirus 4, Human Nuclear Antigens
|
Below are MeSH descriptors whose meaning is more general than "Epstein-Barr Virus Nuclear Antigens".
Below are MeSH descriptors whose meaning is more specific than "Epstein-Barr Virus Nuclear Antigens".
This graph shows the total number of publications written about "Epstein-Barr Virus Nuclear Antigens" by people in this website by year, and whether "Epstein-Barr Virus Nuclear Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 2 | 2 |
| 1995 | 0 | 3 | 3 |
| 1997 | 1 | 1 | 2 |
| 1998 | 1 | 1 | 2 |
| 1999 | 0 | 4 | 4 |
| 2000 | 3 | 0 | 3 |
| 2001 | 4 | 0 | 4 |
| 2002 | 2 | 1 | 3 |
| 2003 | 1 | 0 | 1 |
| 2004 | 4 | 0 | 4 |
| 2005 | 2 | 0 | 2 |
| 2012 | 1 | 0 | 1 |
| 2014 | 1 | 1 | 2 |
| 2015 | 2 | 1 | 3 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Epstein-Barr Virus Nuclear Antigens" by people in Profiles.
-
Race-Dependent Differences in Risk, Genomics, and Epstein-Barr Virus Exposure in Monoclonal Gammopathies: Results of SWOG S0120. Clin Cancer Res. 2020 11 15; 26(22):5814-5819.
-
First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus. mBio. 2019 09 17; 10(5).
-
Epstein-Barr Virus (EBV)-derived BARF1 encodes CD4- and CD8-restricted epitopes as targets for T-cell immunotherapy. Cytotherapy. 2019 02; 21(2):212-223.
-
The EBNA-2 N-Terminal Transactivation Domain Folds into a Dimeric Structure Required for Target Gene Activation. PLoS Pathog. 2015 May; 11(5):e1004910.
-
Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival. EBioMedicine. 2015 Jun; 2(6):572-82.
-
EBNA2 and Its Coactivator EBNA-LP. Curr Top Microbiol Immunol. 2015; 391:35-59.
-
Complementation of antigen-presenting cells to generate T lymphocytes with broad target specificity. J Immunother. 2014 May; 37(4):193-203.
-
Systemic inflammatory response syndrome after administration of unmodified T lymphocytes. Mol Ther. 2014 Jun; 22(6):1134-1138.
-
A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1). PLoS Genet. 2013; 9(1):e1003147.
-
Improving T-cell therapy for epstein-barr virus lymphoproliferative disorders. J Clin Oncol. 2013 Jan 01; 31(1):5-7.